Oral Solid Dosage Contract Manufacturing Market
完整報告名稱與涵蓋範圍
Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report By Product Type (Tablets, Capsules, Powders, Granules), Mechanism (Immediate-Release, Delayed-Release, And Controlled-Release), And End-User (Large-Size Companies, Medium- & Small-Size Companies), Region And Segment Forecasts, 2025-2034
報告摘要
Valued at USD 35.6 Bn as of 2024, the global Oral Solid Dosage Contract Manufacturing Market is set to climb to USD 63.5 Bn by 2034, reflecting a compound annual growth rate of 6.0% over the 2025–2034 period.
At its core, Oral Solid Dosage Contract Manufacturing pertains to the complexity of new drug compounds will all contribute to the market's expansion. Stakeholders across the healthcare landscape are mountingly turning to these solutions to meet contemporary demands.
Several factors contribute to this trajectory, including heightened need next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold marked shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and mounting investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Oral Solid Dosage Contract Manufacturing Market Snapshot
Chapter 4. Global Oral Solid Dosage Contract Manufacturing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product Type:
5.2.1. Tablets
5.2.2. Capsules
5.2.3. Powders
5.2.4. Granules
5.2.5. Others
Chapter 6. Market Segmentation 2: by Mechanism Estimates & Trend Analysis
6.1. by Mechanism & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Mechanism:
6.2.1. Immediate Release
6.2.2. Delayed Release
6.2.3. Controlled Release
Chapter 7. Market Segmentation 3: by End-user Estimates & Trend Analysis
7.1. by End-user & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-user:
7.2.1. Large Size Companies
7.2.2. Medium & Small Size Companies
7.2.3. Others
Chapter 8. Oral Solid Dosage Contract Manufacturing Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
8.1.2. North America Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Mechanism, 2021-2034
8.1.3. North America Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
8.1.4. North America Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
8.2.2. Europe Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Mechanism, 2021-2034
8.2.3. Europe Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
8.2.4. Europe Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
8.3.2. Asia Pacific Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Mechanism, 2021-2034
8.3.3. Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
8.3.4. Asia Pacific Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
8.4.2. Latin America Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Mechanism, 2021-2034
8.4.3. Latin America Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
8.4.4. Latin America Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
8.5.2. Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Mechanism, 2021-2034
8.5.3. Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
8.5.4. Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Catalent, Inc.
9.2.2. Lonza Group
9.2.3. Piramal Pharma Solutions
9.2.4. Aenova
9.2.5. Jubilant
9.2.6. Boehringer Ingelheim
9.2.7. AbbVie Contract Manufacturing
9.2.8. Patheon
9.2.9. Recipharm
9.2.10. Next Pharma AB
9.2.11. Siegfried AG
9.2.12. Corden Pharma
9.2.13. Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們